Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL)
Status:
Completed
Trial end date:
2020-11-15
Target enrollment:
Participant gender:
Summary
Single center, pilot study to evaluate the safety and efficacy topical administration of
WP1220 in subjects with Stage I, II or III Mycosis Fungoides (CTCL)